Strengthen Donor Qualification & Traceability Frameworks
As donor-derived starting materials play an increasingly important role in allogeneic cell therapy development, quality and regulatory teams must ensure robust donor qualification, documentation, and traceability processes are in place.
This summit provides an opportunity to benchmark approaches and learn from industry leaders tackling these challenges across development and manufacturing.
Why Attend?
Discover strategies for:
Strengthening donor qualification to reduce compliance risk
Improving donor traceability to support regulatory confidence
Managing donor-related risks to protect product quality
Building regulatory readiness to accelerate program progression
Developing quality systems that support commercial expansion
Leave With Insights On:
- Qualification approaches that strengthen donor quality assurance
- Traceability frameworks that support end-to-end compliance
- Donor management strategies that enable confident scale-up
- Aligning compliance and efficiency to streamline operations
Explore the Full Event Guide
- Discover donor selection strategies from Cellectis, Mesoblast, Atara Bio, and Caribou Bio to improve clinical outcomes
- Explore donor sourcing from cord blood, PBMCs, and iPSCs to benchmark strategies, and gain clarity on where the field is moving
- Review the full agenda, speakers, and sessions to align team priorities
- Identify valuable networking opportunities to maximize connections with peers and providers